|Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling.|
|PMID: 18056465 Owner: NLM Status: MEDLINE|
|Platelet-derived growth factor-D (PDGF-D) signaling plays critical roles in the pathogenesis and progression of human malignancies; however, the precise mechanism by which PDGF-D causes tumor cell invasion and angiogenesis remain unclear. Because Notch-1, nuclear factor-kappaB (NF-kappaB), vascular endothelial growth factor (VEGF), and matrix metalloproteinases (MMP) are critically involved in the processes of tumor cell invasion and metastasis, we investigated whether PDGF-D down-regulation could be mechanistically associated with the down-regulation of Notch-1, NF-kappaB, VEGF, and MMP-9, resulting in the inhibition of tumor cell invasion and angiogenesis. Our data showed that down-regulation of PDGF-D leads to the inactivation of Notch-1 and NF-kappaB DNA-binding activity and, in turn, down regulates the expression of its target genes, such as VEGF and MMP-9. We also found that the down-regulation of PDGF-D by small interfering RNA (siRNA) decreased tumor cell invasion, whereas PDGF-D overexpression by cDNA transfection led to increased cell invasion. Consistent with these results, we also found that the down-regulation of PDGF-D not only decreased MMP-9 mRNA and its protein expression but also inhibited the processing of pro-MMP-9 protein to its active form. Moreover, conditioned medium from PDGF-D siRNA-transfected cells showed reduced levels of VEGF and, in turn, inhibited the tube formation of human umbilical vascular endothelial cells, suggesting that down-regulation of PDGF-D leads to the inhibition of angiogenesis. Taken together, we conclude that the down-regulation of PDGF-D by novel approaches could lead to the down-regulation of Notch-1 and, in turn, inactivate NF-kappaB and its target genes (i.e., MMP-9 and VEGF), resulting in the inhibition of invasion and angiogenesis.|
|Zhiwei Wang; Dejuan Kong; Sanjeev Banerjee; Yiwei Li; N Volkan Adsay; James Abbruzzese; Fazlul H Sarkar|
Related Documents :
|8469035 - The age-dependent proliferation of rat aortic smooth muscle cells is independent of dif...
7752595 - Cellular events in the evolution of experimental diabetic nephropathy.
21454305 - Enhanced expression of ephrins and thrombospondins in the dermis of patients with early...
21528155 - All-trans retinoic acid upregulates reduced cd38 transcription in lymphoblastoid cell l...
8219755 - Adhesion molecule profile and malignancy of melanocytic lesions.
15735325 - Nitric oxide synthase and arginase expression changes in the rat perirhinal and entorhi...
|Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't|
|Title: Cancer research Volume: 67 ISSN: 1538-7445 ISO Abbreviation: Cancer Res. Publication Date: 2007 Dec|
|Created Date: 2007-12-06 Completed Date: 2008-01-22 Revised Date: -|
Medline Journal Info:
|Nlm Unique ID: 2984705R Medline TA: Cancer Res Country: United States|
|Languages: eng Pagination: 11377-85 Citation Subset: IM|
|Department of Pathology, Karmanos Cancer Institute, Wayne State University, 9374 Scott Hall, 540 East Canfield, Detroit, MI 48201, USA.|
|APA/MLA Format Download EndNote Download BibTex|
prevention & control
Apoptosis / physiology
Electrophoretic Mobility Shift Assay
Endothelium, Vascular / cytology, metabolism
Fluorescent Antibody Technique
Lymphokines / antagonists & inhibitors*, genetics, metabolism
Matrix Metalloproteinase 9 / antagonists & inhibitors, genetics, metabolism
NF-kappa B / antagonists & inhibitors*, genetics, metabolism
Neoplasm Invasiveness / pathology
Neovascularization, Pathologic / pathology
Pancreatic Neoplasms / blood supply*, metabolism*, prevention & control
Pancreatitis, Chronic / genetics, prevention & control
Platelet-Derived Growth Factor / antagonists & inhibitors*, genetics, metabolism
RNA, Small Interfering / pharmacology
Receptor, Notch1 / antagonists & inhibitors*, genetics, metabolism
Umbilical Veins / cytology, metabolism
Vascular Endothelial Growth Factor A / antagonists & inhibitors, genetics, metabolism
|1P20-CA010193-01/CA/NCI NIH HHS; 5R01CA101870-05/CA/NCI NIH HHS|
|0/Lymphokines; 0/NF-kappa B; 0/NOTCH1 protein, human; 0/PDGFD protein, human; 0/Platelet-Derived Growth Factor; 0/RNA, Small Interfering; 0/Receptor, Notch1; 0/VEGFA protein, human; 0/Vascular Endothelial Growth Factor A; EC 184.108.40.206/Matrix Metalloproteinase 9|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Genetic alterations in the tyrosine kinase transcriptome of human cancer cell lines.
Next Document: Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish.